The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines

Author: Baudner B.C.   Giuliani M.M.   Verhoef J.C.   Rappuoli R.   Junginger H.E.   Giudice G.D.  

Publisher: Elsevier

ISSN: 0264-410X

Source: Vaccine, Vol.21, Iss.25, 2003-09, pp. : 3837-3844

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content